221 List of publications Feenstra RGT, Woudstra J, Bijloo I, Vink CEM, Boerhout CKM, de Waard GA, et al. Postspastic flow recovery time to document vasospasm induced ischemia during acetylcholine provocation testing. Int J Cardiol Heart Vasc. 2023;47:101220. Woudstra J, Feenstra RGT, Vink CEM, Marques KMJ, Boerhout CKM, de Jong EAM, et al. Comparison of the Diagnostic Yield of Intracoronary Acetylcholine Infusion and Acetylcholine Bolus Injection Protocols During Invasive Coronary Function Testing. Am J Cardiol. 2024;217:49-58. Woudstra J, Vink CEM, Schipaanboord DJM, Eringa EC, den Ruijter HM, Feenstra RGT, et al. Meta-analysis and systematic review of coronary vasospasm in ANOCA patients: Prevalence, clinical features and prognosis. Front Cardiovasc Med. 2023;10:1129159. Vink CEM, Woudstra J, Lee JM, Boerhout CKM, Cook CM, Hoshino M, et al. Sex differences in prevalence and outcomes of the different endotypes of chronic coronary syndrome in symptomatic patients undergoing invasive coronary angiography: Insights from the global ILIAS invasive coronary physiology registry. Atherosclerosis. 2023;384:117167. Feenstra RGT, Boerhout CKM, Vink CEM, Woudstra J, Wittekoek ME, de Waard GA, et al. Haemodynamic characterisation of different endotypes in coronary artery vasospasm in reaction to acetylcholine. Int J Cardiol Heart Vasc. 2022;42:101105. Feenstra RGT, Boerhout CKM, Woudstra J, Vink CEM, Wittekoek ME, de Waard GA, et al. Presence of Coronary Endothelial Dysfunction, Coronary Vasospasm, and AdenosineMediated Vasodilatory Disorders in Patients With Ischemia and Nonobstructive Coronary Arteries. Circ Cardiovasc Interv. 2022;15(8):e012017. Vink CEM, van de Hoef TP, Götte MJW, Eringa EC, Appelman Y. Reduced Microvascular Blood Volume as a Driver of Coronary Microvascular Disease in Patients With Non-obstructive Coronary Artery Disease: Rationale and Design of the MICORDIS Study. Front Cardiovasc Med. 2021;8:730810. Zweerink A, Friedman DJ, Klem I, Ven PMvd, Vink C, Biesbroek PS, et al. Segment Length in Cine Strain Analysis Predicts Cardiac Resynchronization Therapy Outcome Beyond Current Guidelines. Circulation: Cardiovascular Imaging. 2021;14(7):e012350. Zweerink A, Friedman DJ, Klem I, van de Ven PM, Vink C, Biesbroek PS, et al. Size Matters: Normalization of QRS Duration to Left Ventricular Dimension Improves Prediction of Long-Term Cardiac Resynchronization Therapy Outcome. Circ Arrhythm Electrophysiol. 2018;11(12):e006767. A
RkJQdWJsaXNoZXIy MTk4NDMw